Nov 5 (Reuters) - REDCARE PHARMACY NV RDC.DE :
* REDCARE PHARMACY NV - ON TRACK TO DELIVER ALL ELEMENTS OF
FY2024
GUIDANCE
* REDCARE PHARMACY NV - TOTAL GROUP SALES GROWTH 21% IN Q3
TO EUR
575M
* REDCARE PHARMACY NV - ON TRACK TO DELIVER ALL ELEMENTS OF
FY2024
GUIDANCE
* REDCARE PHARMACY NV - POSITIVE ADJUSTED. EBITDA MARGIN OF
2% IN
Q3 AND 2.3% YEAR TO DATE
* REDCARE PHARMACY NV - MID- TO LONGER-TERM GUIDANCE
CONTINUES TO
BE AN ADJUSTED EBITDA MARGIN IN EXCESS OF 8%
Source text: ID:nEQ79DnSTa
Further company coverage: RDC.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))